Stock Price
76.49
Daily Change
-1.41%
Monthly
-6.32%
Yearly
-37.52%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Kyowa Hakko Kirin 3,400.00 -25.00 -0.73% 18.06%
Acadia Pharmaceuticals 18.79 -0.99 -5.01% -66.45%
Agios Pharmaceuticals 36.45 -0.80 -2.15% -18.40%
Alnylam Pharmaceuticals 188.53 -0.27 -0.14% 45.18%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Aptinyx Inc 2.42 0.01 0.41% -29.24%
BioCryst Pharmaceuticals 12.48 -0.02 -0.16% 143.27%
Bluebird Bio 10.50 -0.26 -2.42% -76.17%
BioMarin Pharmaceutical 87.58 -1.99 -2.22% 8.93%
Epizyme 3.37 -0.25 -6.91% -72.22%
Esperion Therapeutics 7.78 0.09 1.17% -71.21%
GW Pharmaceuticals 218.96 0 0% 108.53%
Insmed 28.93 -1.68 -5.49% -27.31%
Ionis Pharmaceuticals 29.05 -0.71 -2.39% -42.18%
Karyopharm Therapeutics 7.27 -0.43 -5.58% -51.98%
MacroGenics 18.77 -0.88 -4.48% -18.64%
Moderna Inc 329.63 56.24 20.57% 159.49%
Mirati Therapeutics 136.76 -4.44 -3.14% -41.19%
Neurocrine Biosciences 86.98 -0.88 -1.00% -8.98%
Puma Biotechnology 3.23 -0.26 -7.33% -72.51%
PTC Therapeutics 38.06 -1.35 -3.43% -40.52%
Ultragenyx Pharmaceutical 76.49 -1.09 -1.41% -37.52%
Regeneron Pharmaceuticals 643.35 -4.83 -0.75% 25.15%
Sarepta Therapeutics 79.62 -1.36 -1.68% -42.78%
Vertex Pharmaceuticals 183.59 -2.65 -1.42% -19.02%
Immunic Inc. 8.61 -0.58 -6.31% -50.94%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Xoma 21.86 -1.65 -7.02% -31.79%

Indexes Price Day Year
NASDAQ 15492 -353.57 -2.23% 26.92%
US2000 2246 -85.52 -3.67% 21.06%

Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. The Company's therapies and clinical-stage pipeline consist of four product categories, such as biologics, small molecules, gene therapy and nucleic acid product candidates. Its three approved product candidates include Crysvita (burosumab), for the treatment of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO), Mepsevii (vestronidase alfa), for the treatment of mucopolysaccharidosis VII (MPSVII) or Sly Syndrome and Dojolvi (triheptanoin), for the treatment of long-chain fatty acid oxidation disorders (LC-FAOD). Its clinical product candidates include DTX401, for the treatment of glycogen storage disease type Ia (GSDIa), DTX301, for the treatment of ornithine transcarbamylase (OTC), UX143, GTX-102, UX701 and UX053.